Nutra Pharma Chairman and CEO, Rik J Deitsch, Presents at NASDAQ MarketSite on April 27, 2010 Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. Currently, the Company markets and sells Cobroxin and Nyloxin, treatments for moderate to severe chronic pain. http://www.NutraPharma.com
Nutra Pharma is a biotechnology company developing treatments to Multiple Sclerosis, Herpes, HIV and Adrenomyeloneuropathy. Come explore what Nutra Pharma is doing by watching this short video or by visiting us online at http://www.NutraPharma.com